• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Long-Term Safety and Efficacy of Subcutaneous Immunoglobulin IgPro20 in Chronic Inflammatory Demyelinating Polyneuropathy

home / publications / supplement / long-term-safety-and-efficacy-of-subcutaneous-immunoglobulin-igpro20-in-chronic-inflammatory-dem
© 2024 MJH Life Sciences
AJMC®
All rights reserved.